ERK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE48635
SERIAL NO

16419141

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELI LILLY AND COMPANYINDIANAPOLIS IN 46285

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cortez, Guillermo S Indianapolis, US 11 8
Joseph, Sajan Carmel, US 31 244
McLean, Johnathan Alexander Indianapolis, US 13 18
McMillen, William T Indianapolis, US 5 17
Rodriguez, Michael John Indianapolis, US 11 50
Zhao, Gaiying Carmel, US 12 39

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 13, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 13, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 13, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00